InVitro International (IVRO)

[adijas]

Filings out. Some interesting info in it.

Cash $ 421.000, assets 1.3 million, liabilities just $ 49,170

Net profit last Q $.002 per share


The CORROSITEX™ assay has been marketed since 1991 and the IRRITECTION® assays have been marketed since 1989. All three test methods are currently marketed by Company internal personnel through industry contacts, standard advertising and a strategic alliance with INT.E.G.RA, a division of Italy based Res Pharma, which sells and distributes the Company’s test kits and laboratory testing services in Italy and 21 other countries around the world. The Company is also in the process of developing a targeted social media marketing program.


As a result of the OECD Expert Committee meeting in November 2017, the Company’s Ocular IRRITECTION® test method has now moved on to the next phase of the OECD adoption process for acceptance as a substitute for animal testing on all future cosmetic products.

https://backend.otcmarkets.com/otcapi/company/financial-report/193130/content

https://backend.otcmarkets.com/otcapi/company/financial-report/193126/content